Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck ProQuad Clears FDA; MMR/V Vaccine Will Begin Shipping In Weeks

Executive Summary

FDA's Sept. 6 clearance of Merck's measles, mumps, rubella and varicella vaccine ProQuad covers primary and second-dose use of the vaccine

You may also be interested in...



Gardasil Goes To FDA; Merck Hopes For Mid-Year Approval Of HPV Vaccine

Merck could have a strong case for priority review of its human papillomavirus vaccine Gardasil

Gardasil Goes To FDA; Merck Hopes For Mid-Year Approval Of HPV Vaccine

Merck could have a strong case for priority review of its human papillomavirus vaccine Gardasil

Varicella Two-Dose Vaccination Recommended For Teens And Older Cohorts

Two-dose varicella vaccination for persons ages 13 years and older without evidence of immunity is recommended by the Centers for Disease Control & Prevention Advisory Committee on Immunization Practices

Related Content

Topics

UsernamePublicRestriction

Register

PS046309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel